Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN)

NCT02597322 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

cT2a N0NxM0 Renal Tumor

Interventions

DRUG: AXITINIB

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]